The DAPA-HF Trial: A Momentous Victory in the War against Heart Failure

被引:40
作者
Bhatt, Deepak L. [1 ]
Verma, Subodh [2 ]
Braunwald, Eugene [1 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, Dept Surg,Div Cardiac Surg, Toronto, ON, Canada
关键词
D O I
10.1016/j.cmet.2019.10.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In a randomized trial of patients with heart failure and reduced ejection fraction, the SGLT2 inhibitor dapagliflozin markedly reduced mortality and worsening heart failure (McMurray et al., 2019). Remarkably, these benefits seemed to be similar in people with and without diabetes. These data usher in a new paradigm in the treatment of heart failure.
引用
收藏
页码:847 / 849
页数:3
相关论文
共 13 条
  • [1] The war against heart failure: the Lancet lecture
    Braunwald, Eugene
    [J]. LANCET, 2015, 385 (9970) : 812 - 824
  • [2] Byrne Nikole J, 2017, JACC Basic Transl Sci, V2, P347, DOI 10.1016/j.jacbts.2017.07.003
  • [3] Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction
    Connelly, Kim A.
    Zhang, Yanling
    Visram, Aylin
    Advani, Andrew
    Batchu, Sri N.
    Desjardins, Jean-Francois
    Thai, Kerri
    Gilbert, Richard E.
    [J]. JACC-BASIC TO TRANSLATIONAL SCIENCE, 2019, 4 (01): : 27 - 37
  • [4] Can We DECLARE a Victory against Cardio-Renal Disease in Diabetes?
    Connelly, Kim A.
    Bhatt, Deepak L.
    Verma, Subodh
    [J]. CELL METABOLISM, 2018, 28 (06) : 813 - 815
  • [5] SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus
    Hess, David A.
    Terenzi, Daniella C.
    Trac, Justin Z.
    Quan, Adrian
    Mason, Tamique
    Al-Omran, Mohammed
    Bhatt, Deepak L.
    Dhingra, Natasha
    Rotstein, Ori D.
    Leiter, Lawrence A.
    Zinman, Bernard
    Sabongui, Sandra
    Yan, Andrew T.
    Teoh, Hwee
    Mazer, C. David
    Connelly, Kim A.
    Verma, Subodh
    [J]. CELL METABOLISM, 2019, 30 (04) : 609 - 613
  • [6] Empagliflozin's Fuel Hypothesis: Not so Soon
    Lopaschuk, Gary D.
    Verma, Subodh
    [J]. CELL METABOLISM, 2016, 24 (02) : 200 - 202
  • [7] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21) : 1995 - 2008
  • [8] Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
    Scirica, Benjamin M.
    Bhatt, Deepak L.
    Braunwald, Eugene
    Steg, P. Gabriel
    Davidson, Jaime
    Hirshberg, Boaz
    Ohman, Peter
    Frederich, Robert
    Wiviott, Stephen D.
    Hoffman, Elaine B.
    Cavender, Matthew A.
    Udell, Jacob A.
    Desai, Nihar R.
    Mosenzon, Ofri
    McGuire, Darren K.
    Ray, Kausik K.
    Leiter, Lawrence A.
    Raz, Itamar
    Braunwald, Eugene
    Bhatt, Deepak L.
    Scirica, Benjamin M.
    Udell, Jacob A.
    Cavender, Matthew A.
    Desai, Nihar
    Abrahamsen, Timothy
    Grossman, Michelle
    Morin, Suzanne
    Im, Kyungah
    Hoffman, Elaine
    Gabovitch, Daniel
    Pricken, Alexandra
    Mosenzon, Ofri
    Buskila, Alona
    Ohman, Peter
    Hirshberg, Boaz
    Stahre, Christina
    Price, Deborah
    Billing-Clason, Solveig
    Sabel, Karin
    Monyak, John
    Sjostrand, Mikalea
    Wei, Cheryl
    Lu, Jane
    Miller, Elinor
    Raichlen, Joel
    Fitt, Sandy
    Frederich, Robert
    Iqbal, Nayyar
    Donovan, Mark
    Davidson, Jaime A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14) : 1317 - 1326
  • [9] Verma S., 2019, CIRCULATION, DOI [10.1161/CIRCULATIONAHA.1119.042375, DOI 10.1161/CIRCULATIONAHA.1119.042375]
  • [10] Verma Subodh, 2018, JACC Basic Transl Sci, V3, P575, DOI 10.1016/j.jacbts.2018.07.006